Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 4 | 0 | 0 | 4 |
Chain A, HADH2 protein | 2 | 0 | 0 | 2 |
Chain B, HADH2 protein | 2 | 0 | 0 | 2 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 2 | 0 | 0 | 2 |
Chain A, 2-oxoglutarate Oxygenase | 4 | 0 | 0 | 4 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 1 | 0 | 0 | 1 |
Luciferase | 2 | 0 | 0 | 2 |
endonuclease IV | 2 | 0 | 0 | 2 |
15-lipoxygenase, partial | 4 | 0 | 0 | 4 |
WRN | 1 | 0 | 0 | 1 |
RAR-related orphan receptor gamma | 7 | 0 | 0 | 7 |
USP1 protein, partial | 5 | 0 | 0 | 5 |
Microtubule-associated protein tau | 4 | 0 | 0 | 4 |
AR protein | 11 | 0 | 0 | 11 |
aldehyde dehydrogenase 1 family, member A1 | 6 | 0 | 0 | 6 |
estrogen receptor 2 (ER beta) | 5 | 0 | 0 | 5 |
nuclear receptor subfamily 1, group I, member 3 | 8 | 0 | 0 | 8 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 8 | 0 | 0 | 8 |
retinoid X nuclear receptor alpha | 7 | 0 | 0 | 7 |
estrogen nuclear receptor alpha | 11 | 0 | 0 | 11 |
G | 4 | 0 | 0 | 4 |
cytochrome P450 2D6 | 4 | 0 | 0 | 4 |
peroxisome proliferator activated receptor gamma | 6 | 0 | 0 | 6 |
aryl hydrocarbon receptor | 5 | 0 | 0 | 5 |
thyroid stimulating hormone receptor | 4 | 0 | 0 | 4 |
Histone H2A.x | 3 | 0 | 0 | 3 |
polyunsaturated fatty acid lipoxygenase ALOX12 | 1 | 0 | 0 | 1 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 2 | 0 | 0 | 2 |
chromobox protein homolog 1 | 6 | 0 | 0 | 6 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 3 | 0 | 0 | 4 |
potassium voltage-gated channel subfamily H member 2 isoform d | 4 | 0 | 0 | 4 |
histone deacetylase 9 isoform 3 | 2 | 0 | 0 | 2 |
importin subunit beta-1 isoform 1 | 3 | 0 | 0 | 3 |
mitogen-activated protein kinase 1 | 2 | 0 | 0 | 2 |
flap endonuclease 1 | 1 | 0 | 0 | 1 |
serine/threonine-protein kinase PLK1 | 1 | 0 | 0 | 1 |
snurportin-1 | 3 | 0 | 0 | 3 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 9 | 0 | 0 | 9 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 2 | 0 | 0 | 2 |
tumor susceptibility gene 101 protein | 1 | 0 | 0 | 1 |
DNA polymerase eta isoform 1 | 1 | 0 | 0 | 1 |
DNA polymerase iota isoform a (long) | 3 | 0 | 0 | 3 |
dual specificity tyrosine-phosphorylation-regulated kinase 1A | 0 | 0 | 0 | 1 |
geminin | 10 | 0 | 0 | 10 |
DNA polymerase kappa isoform 1 | 2 | 0 | 0 | 2 |
Vpr | 2 | 0 | 0 | 2 |
survival motor neuron protein isoform d | 2 | 0 | 0 | 2 |
cytochrome P450 3A4 isoform 1 | 3 | 0 | 0 | 3 |
histone acetyltransferase KAT2A isoform 1 | 2 | 0 | 0 | 2 |
kelch-like ECH-associated protein 1 | 0 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit pi | 3 | 0 | 0 | 3 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 1 | 0 | 0 | 1 |
Interferon beta | 5 | 0 | 0 | 5 |
HLA class I histocompatibility antigen, B alpha chain | 4 | 0 | 0 | 4 |
Transthyretin | 0 | 1 | 0 | 1 |
Gag-Pol polyprotein | 0 | 1 | 0 | 1 |
Cellular tumor antigen p53 | 10 | 0 | 0 | 10 |
Apoptosis regulator Bcl-2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit delta | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 3 | 0 | 0 | 3 |
D(3) dopamine receptor | 0 | 1 | 0 | 1 |
Glutamate receptor 1 | 1 | 0 | 0 | 1 |
Glutamate receptor 2 | 4 | 0 | 0 | 4 |
Glutamate receptor 3 | 1 | 0 | 0 | 1 |
Glutamate receptor 4 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 3 | 0 | 0 | 3 |
Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 3 | 0 | 0 | 3 |
Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 3 | 0 | 0 | 3 |
Histamine H2 receptor | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit beta-3 | 3 | 0 | 0 | 3 |
Guanine nucleotide-binding protein G | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-2 | 3 | 0 | 0 | 3 |
Inositol monophosphatase 1 | 1 | 0 | 0 | 1 |
Induced myeloid leukemia cell differentiation protein Mcl-1 | 0 | 1 | 0 | 1 |
TAR DNA-binding protein 43 | 2 | 0 | 0 | 2 |
Cytochrome P450 1B1 | 0 | 1 | 0 | 1 |
RmtA | 0 | 1 | 0 | 1 |
Reverse transcriptase/RNaseH | 0 | 1 | 0 | 1 |
GABA theta subunit | 3 | 0 | 0 | 3 |
Inositol hexakisphosphate kinase 1 | 4 | 0 | 0 | 4 |
Protein arginine N-methyltransferase 1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit epsilon | 3 | 0 | 0 | 3 |
cytochrome P450 2C9, partial | 4 | 0 | 0 | 4 |
phosphoglycerate kinase | 1 | 0 | 0 | 1 |
Chain A, Beta-lactamase | 2 | 0 | 0 | 2 |
interleukin 8 | 2 | 0 | 0 | 2 |
glp-1 receptor, partial | 4 | 0 | 0 | 4 |
pregnane X receptor | 2 | 0 | 0 | 2 |
ATAD5 protein, partial | 1 | 0 | 0 | 1 |
Fumarate hydratase | 3 | 0 | 0 | 3 |
NFKB1 protein, partial | 1 | 0 | 0 | 1 |
PPM1D protein | 1 | 0 | 0 | 1 |
TDP1 protein | 10 | 0 | 0 | 10 |
GLI family zinc finger 3 | 6 | 0 | 0 | 6 |
Thrombopoietin | 1 | 0 | 0 | 1 |
Smad3 | 3 | 0 | 0 | 3 |
progesterone receptor | 3 | 0 | 0 | 3 |
glucocorticoid receptor [Homo sapiens] | 6 | 0 | 0 | 6 |
retinoic acid nuclear receptor alpha variant 1 | 7 | 0 | 0 | 7 |
estrogen-related nuclear receptor alpha | 8 | 0 | 0 | 8 |
farnesoid X nuclear receptor | 2 | 0 | 0 | 2 |
pregnane X nuclear receptor | 6 | 0 | 0 | 6 |
polyprotein | 3 | 0 | 0 | 3 |
67.9K protein | 6 | 0 | 0 | 6 |
Parkin | 1 | 0 | 0 | 1 |
peroxisome proliferator-activated receptor delta | 5 | 0 | 0 | 5 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 3 | 0 | 0 | 3 |
arylsulfatase A | 1 | 0 | 0 | 1 |
IDH1 | 3 | 0 | 0 | 3 |
euchromatic histone-lysine N-methyltransferase 2 | 5 | 0 | 0 | 5 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 6 | 0 | 0 | 6 |
activating transcription factor 6 | 2 | 0 | 0 | 2 |
Bloom syndrome protein isoform 1 | 2 | 0 | 0 | 2 |
peripheral myelin protein 22 isoform 1 | 1 | 0 | 0 | 1 |
hemoglobin subunit beta | 1 | 0 | 0 | 1 |
cellular tumor antigen p53 isoform a | 1 | 0 | 0 | 1 |
thyroid hormone receptor beta isoform 2 | 7 | 0 | 0 | 7 |
huntingtin isoform 2 | 1 | 0 | 0 | 1 |
ras-related protein Rab-9A | 1 | 0 | 0 | 1 |
serine/threonine-protein kinase mTOR isoform 1 | 2 | 0 | 0 | 2 |
urokinase-type plasminogen activator precursor | 4 | 0 | 0 | 4 |
plasminogen precursor | 4 | 0 | 0 | 4 |
urokinase plasminogen activator surface receptor precursor | 4 | 0 | 0 | 4 |
peripheral myelin protein 22 | 5 | 0 | 0 | 5 |
muscarinic acetylcholine receptor M1 | 1 | 0 | 0 | 1 |
lamin isoform A-delta10 | 6 | 0 | 0 | 6 |
Integrin beta-3 | 1 | 0 | 0 | 1 |
Integrin alpha-IIb | 1 | 0 | 0 | 1 |
Adenosine receptor A3 | 0 | 1 | 0 | 1 |
DNA (cytosine-5)-methyltransferase 1 | 0 | 1 | 0 | 1 |
Adenosine receptor A2a | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 1 | 0 | 1 |
D(1A) dopamine receptor | 2 | 0 | 0 | 2 |
Nuclear receptor ROR-gamma | 3 | 0 | 0 | 3 |
Spike glycoprotein | 4 | 0 | 0 | 4 |
Multidrug and toxin extrusion protein 1 | 0 | 1 | 0 | 1 |
Histone-lysine N-methyltransferase EHMT2 | 0 | 1 | 0 | 1 |
ATPase family AAA domain-containing protein 5 | 3 | 0 | 0 | 3 |
Ataxin-2 | 4 | 0 | 0 | 4 |
ATP-dependent phosphofructokinase | 2 | 0 | 0 | 2 |
apical membrane antigen 1, AMA1 | 1 | 0 | 0 | 1 |
thyroid stimulating hormone receptor | 2 | 0 | 0 | 2 |
EWS/FLI fusion protein | 6 | 0 | 0 | 6 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 2 | 0 | 0 | 2 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 2 | 0 | 0 | 2 |
lethal factor (plasmid) | 1 | 0 | 0 | 1 |
ATP-binding cassette sub-family C member 3 | 0 | 4 | 0 | 4 |
Multidrug resistance-associated protein 4 | 0 | 4 | 0 | 4 |
Bile salt export pump | 0 | 4 | 0 | 4 |
Matrix metalloproteinase-9 | 0 | 1 | 0 | 1 |
Disintegrin and metalloproteinase domain-containing protein 17 | 2 | 0 | 0 | 2 |
Canalicular multispecific organic anion transporter 1 | 0 | 3 | 0 | 3 |
Carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 15 | 0 | 1 | 0 | 1 |
thioredoxin reductase | 6 | 0 | 0 | 6 |
phosphopantetheinyl transferase | 4 | 0 | 0 | 4 |
LMP1 [Human herpesvirus 4] | 0 | 0 | 0 | 2 |
thyroid hormone receptor beta isoform a | 1 | 0 | 0 | 1 |
nuclear receptor coactivator 1 isoform 1 [Homo sapiens] | 0 | 1 | 0 | 1 |
transactivating tegument protein VP16 [Human herpesvirus 1] | 0 | 1 | 0 | 1 |
nuclear receptor coactivator 3 isoform a | 0 | 1 | 0 | 1 |
Thymidine kinase 2, mitochondrial | 0 | 1 | 0 | 1 |
Voltage-dependent calcium channel gamma-2 subunit | 3 | 0 | 0 | 3 |
Thymidine kinase, cytosolic | 0 | 1 | 0 | 2 |
Thymidine kinase | 0 | 1 | 0 | 1 |
Thymidylate synthase | 0 | 0 | 0 | 1 |
Cytochrome P450 3A4 | 0 | 1 | 0 | 1 |
Thymidine kinase | 0 | 1 | 0 | 1 |
Deoxycytidine kinase | 0 | 0 | 0 | 1 |
Probable deoxycytidylate deaminase | 0 | 0 | 0 | 1 |
Cytidine deaminase | 0 | 1 | 0 | 2 |
E3 ubiquitin-protein ligase Mdm2 | 0 | 1 | 0 | 1 |
Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 1 | 0 | 1 |
Thymidine kinase | 0 | 1 | 0 | 1 |
Deoxynucleoside kinase | 0 | 1 | 0 | 1 |
heat shock protein beta-1 | 2 | 0 | 0 | 2 |
GTP-binding nuclear protein Ran isoform 1 | 1 | 0 | 0 | 1 |
Rap guanine nucleotide exchange factor 3 | 1 | 0 | 0 | 1 |
Glutathione S-transferase P | 0 | 1 | 0 | 1 |
Alpha-tocopherol transfer protein | 0 | 0 | 1 | 1 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 3 | 0 | 0 | 3 |
corticotropin-releasing hormone receptor 2 | 0 | 1 | 1 | 2 |
corticotropin releasing factor-binding protein | 0 | 1 | 1 | 2 |
glycogen synthase kinase-3 beta isoform 1 | 0 | 0 | 2 | 2 |
5'-nucleotidase | 0 | 1 | 0 | 1 |
Adenosine receptor A3 | 0 | 1 | 0 | 1 |
Adenosine deaminase | 0 | 0 | 0 | 2 |
Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
Pancreatic alpha-amylase | 0 | 1 | 0 | 1 |
Beta-glucuronidase | 0 | 1 | 0 | 1 |
Beta-glucuronidase | 0 | 1 | 0 | 1 |
High mobility group protein B1 | 0 | 0 | 1 | 1 |
Tyrosine-protein phosphatase non-receptor type 1 | 0 | 1 | 0 | 1 |
Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 1 | 1 | 2 |
Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 1 | 1 | 2 |
High mobility group protein B1 | 0 | 0 | 0 | 1 |
Corticosteroid 11-beta-dehydrogenase isozyme 2 | 0 | 1 | 1 | 2 |
Canalicular multispecific organic anion transporter 1 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1B3 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1B2 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1B1 | 0 | 1 | 0 | 1 |
Chain A, Uracil Phosphoribosyltransferase | 0 | 0 | 1 | 1 |
Chain B, Uracil Phosphoribosyltransferase | 0 | 0 | 1 | 1 |
Chain C, Uracil Phosphoribosyltransferase | 0 | 0 | 1 | 1 |
2-dehydropantoate 2-reductase | 0 | 0 | 1 | 1 |
Ras-related protein Rab-7a | 0 | 0 | 1 | 1 |
4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase 9 | 0 | 2 | 0 | 2 |
Chain A, AMINOPEPTIDASE | 0 | 1 | 0 | 1 |
Chain A, AMINOPEPTIDASE | 0 | 1 | 0 | 1 |
Chain A, Leucine Aminopeptidase | 0 | 1 | 0 | 1 |
Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 1 | 0 | 1 |
Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
Large neutral amino acids transporter small subunit 1 | 0 | 1 | 0 | 1 |
Proton-coupled amino acid transporter 1 | 0 | 1 | 0 | 2 |
Phospholipase A-2-activating protein | 0 | 1 | 0 | 1 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 2 | 0 | 0 | 2 |
GLS protein | 1 | 0 | 0 | 1 |
thioredoxin glutathione reductase | 1 | 0 | 0 | 1 |
caspase 7, apoptosis-related cysteine protease | 1 | 0 | 0 | 1 |
glucocerebrosidase | 1 | 0 | 0 | 1 |
caspase-3 | 1 | 0 | 0 | 1 |
Caspase-7 | 1 | 0 | 0 | 1 |
caspase-3 | 1 | 0 | 0 | 1 |
Large neutral amino acids transporter small subunit 1 | 0 | 1 | 0 | 1 |
GALC protein | 1 | 0 | 0 | 1 |
beta-2 adrenergic receptor | 1 | 0 | 0 | 1 |
lysosomal alpha-glucosidase preproprotein | 1 | 0 | 0 | 1 |
mu-type opioid receptor isoform MOR-1 | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 0 | 1 | 1 |
Neuronal acetylcholine receptor subunit alpha-4 | 1 | 0 | 0 | 1 |
Neuronal acetylcholine receptor subunit beta-2 | 1 | 0 | 0 | 1 |
SMAD family member 2 | 2 | 0 | 0 | 2 |
SMAD family member 3 | 2 | 0 | 0 | 2 |
nuclear receptor subfamily 1, group I, member 2 | 1 | 0 | 0 | 1 |
nuclear receptor ROR-gamma isoform 1 | 3 | 0 | 0 | 3 |
Flavin reductase (NADPH) | 0 | 0 | 1 | 1 |
Chain A, PLASMA RETINOL-BINDING PROTEIN PRECURSOR | 0 | 0 | 1 | 1 |
Chain A, Cruzipain | 1 | 0 | 0 | 1 |
acetylcholinesterase | 1 | 0 | 0 | 1 |
vitamin D3 receptor isoform VDRA | 1 | 0 | 0 | 1 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 1 | 0 | 0 | 1 |
Retinol-binding protein 4 | 0 | 0 | 1 | 1 |
Beta-lactoglobulin | 0 | 0 | 1 | 1 |
Amyloid-beta precursor protein | 0 | 1 | 0 | 1 |
Alpha-synuclein | 0 | 1 | 0 | 1 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 1 | 0 | 0 | 1 |
Serine/threonine-protein kinase D3 | 0 | 0 | 1 | 1 |
Protein kinase C gamma type | 0 | 1 | 1 | 2 |
Protein kinase C beta type | 0 | 1 | 1 | 2 |
Luciferin 4-monooxygenase | 0 | 0 | 1 | 1 |
Protein kinase C alpha type | 0 | 1 | 1 | 2 |
Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
Protein kinase C eta type | 0 | 0 | 1 | 1 |
Protein kinase C iota type | 0 | 0 | 1 | 1 |
Protein kinase C epsilon type | 0 | 1 | 1 | 2 |
Protein kinase C theta type | 0 | 0 | 1 | 1 |
Protein kinase C zeta type | 0 | 0 | 1 | 1 |
Protein kinase C delta type | 0 | 1 | 1 | 2 |
Serine/threonine-protein kinase D1 | 0 | 0 | 1 | 1 |
Ras guanyl-releasing protein 3 | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 1 | 0 | 0 | 1 |
acid sphingomyelinase | 1 | 0 | 0 | 1 |
HLA class I histocompatibility antigen, A alpha chain | 0 | 0 | 1 | 1 |
Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
Histamine H1 receptor | 0 | 0 | 1 | 1 |
Adenosylhomocysteinase | 0 | 1 | 0 | 1 |
RNA-directed RNA polymerase | 0 | 1 | 1 | 2 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |